Tandem looks to raise $50m in public offering; shares fall despite Q4 earnings win

Shares in Tandem Diabetes Care (NSDQ:TNDM) fell today, although the medical device maker met expectations on Wall Street with its 4th quarter results.

The San Diego-based company posted losses of -$15.7 million, or -48¢ per share, on sales of $24.8 million for the 3 months ended Dec. 31, for bottom-line loss of -40% on sales loss of -15% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were -48¢, ahead of consensus on The Street, where analysts were looking for sales of $22.8 million.

Get the full story at our sister site, Drug Delivery Business News.

The post Tandem looks to raise $50m in public offering; shares fall despite Q4 earnings win appeared first on MassDevice.

from MassDevice http://ift.tt/2mKEByd